The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Toward in silico structure-based ADMET prediction in drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983) · Journal of Computational Chemistry · doi:10.1002/jcc.540040211 · Cited by 14,944
Atomic structure and chemistry of human serum albumin
He, X. M., & Carter, D. C. (1992) · Nature · doi:10.1038/358209a0 · Cited by 3,824
Carter, D. C., & Ho, J. X. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60640-3 · Cited by 3,187
Basic Methods in Molecular Biology
(1986) · Elsevier eBooks · doi:10.1016/b978-0-444-01082-7.x5001-2 · Cited by 3,134
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., & Curry, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.075 · Cited by 1,941
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Cytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
A structural basis for drug-induced long QT syndrome
Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210244497 · Cited by 944
Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R., & Ball, S. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000794 · Cited by 928
The ATP switch model for ABC transporters
Higgins, C. F., & Linton, K. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb836 · Cited by 748
Shimada, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.257 · Cited by 606
MetaSite: Understanding Metabolism in Human Cytochromes from the Perspective of the Chemist
Cruciani, G., Carosati, E., De Boeck, B., Ethirajulu, K., Mackie, C., Howe, T., & Vianello, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050529c · Cited by 496
Baes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D., & Moore, D. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1544 · Cited by 494
Crystal Structure of Human Cytochrome P450 2D6
Rowland, P., Blaney, F. E., Smyth, M. G., Jones, J. J., Leydon, V. R., Oxbrow, A. K., Lewis, C. J., Tennant, M. G., Modi, S., Eggleston, D. S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511232200 · Cited by 437
Shao, H., He, X., Achnine, L., Blount, J. W., Dixon, R. A., & Wang, X. (2005) · The Plant Cell · doi:10.1105/tpc.105.035055 · Cited by 385
Predictive in silico modeling for hERG channel blockers
Aronov, A. M. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03278-7 · Cited by 267
Physicochemical Features of the hERG Channel Drug Binding Site
Fernandez, D., Ghanta, A., Kauffman, G. W., & Sanguinetti, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310683200 · Cited by 266
FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects
Lagorce, D., Sperandio, O., Galons, H., Miteva, M. A., & Villoutreix, B. O. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-396 · Cited by 263
Self-citationCan we estimate the accuracy of ADME–Tox predictions?
Tetko, I. V., Bruneau, P., Mewes, H.-W., Rohrer, D. C., & Poda, G. I. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.013 · Cited by 243
A Molecular Functional Study on the Interactions of Drugs with Plasma Proteins
Otagiri, M. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.309 · Cited by 228
A Structural Basis for Constitutive Activity in the Human CAR/RXRα Heterodimer
Xu, R. X., Lambert, M. H., Wisely, B. B., Warren, E. N., Weinert, E. E., Waitt, G. M., Williams, J. D., Collins, J. L., Moore, L. B., Willson, T. M., et al. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.042 · Cited by 226
Structural and Chemical Profiling of the Human Cytosolic Sulfotransferases
Allali-Hassani, A., Pan, P. W., Dombrovski, L., Najmanovich, R., Tempel, W., Dong, A., Loppnau, P., Martin, F., Thonton, J., Edwards, A. M., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050097 · Cited by 217
Ekins, S., de Groot, M. J., & Jones, J. P. (2001) · PubMed · Cited by 201
Does Compound I Vary Significantly between Isoforms of Cytochrome P450?
Lonsdale, R., Oláh, J., Mulholland, A. J., & Harvey, J. N. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203157u · Cited by 198
Miley, M. J., Zielinska, A. K., Keenan, J. E., Bratton, S. M., Radominska-Pandya, A., & Redinbo, M. R. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.066 · Cited by 198
In-Silico ADME Models: A General Assessment of their Utility in Drug Discovery Applications
Paul Gleeson, M., Hersey, A., & Hannongbua, S. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611794480927 · Cited by 196
Pharmacogenetics of the major polymorphic metabolizing enzymes
Daly, A. K. (2003) · Fundamental & Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00119.x · Cited by 189
Huang, S.-M. (2004) · Applications of Pharmacokinetic Principles in Drug Development · doi:10.1007/978-1-4419-9216-1_10 · Cited by 181
Dantzig, A. H., Shepard, R. L., Law, K. L., Tabas, L., Pratt, S., Gillespie, J. S., Binkley, S. N., Kuhfeld, M. T., Starling, J. J., & Wrighton, S. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34974-2 · Cited by 179
van Westen, G. J. P., Wegner, J. K., IJzerman, A. P., van Vlijmen, H. W. T., & Bender, A. (2011) · MedChemComm · doi:10.1039/c0md00165a · Cited by 176
Vedani, A., Dobler, M., & Lill, M. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050185q · Cited by 166
Pearlstein, R., Vaz, R., & Rampe, D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205651 · Cited by 163
Structure‐based Drug Metabolism Predictions for Drug Design
Sun, H., & Scott, D. O. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00899.x · Cited by 162
Computational toxicology—a tool for early safety evaluation
Merlot, C. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.010 · Cited by 156
Schönfeld, D. L., Ravelli, R. B. G., Müeller, U., & Skerra, A. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.020 · Cited by 155
Zsila, F., Bikádi, Z., Malik, D., Hári, P., Pechan, I., Bérces, A., & Hazai, E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr284 · Cited by 152
‘Metabolite-likeness’ as a criterion in the design and selection of pharmaceutical drug libraries
Dobson, P. D., Patel, Y., & Kell, D. B. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.011 · Cited by 141
Afzelius, L., Arnby, C. H., Broo, A., Carlsson, L., Isaksson, C., Jurva, U., Kjellander, B., Kolmodin, K., Nilsson, K. L., Raubacher, F., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530600969374 · Cited by 141
Wendt, M. D., Wang, S., Kunzer, A. R., McClellan, W. J., Bruncko, M., Oost, T. K., Ding, H., Joseph, M. K., Zhang, H., Nimmer, P. M., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050754u · Cited by 139
Determination of Energies and Sites of Binding of PFOA and PFOS to Human Serum Albumin
Salvalaglio, M., Muscionico, I., & Carlo, C. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp106584b · Cited by 136
Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR
Krasowski, M. D., Ni, A., Hagey, L. R., & Ekins, S. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.016 · Cited by 132
de Graaf, C., Oostenbrink, C., Keizers, P. H. J., van der Wijst, T., Jongejan, A., & Vermeulen, N. P. E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0508538 · Cited by 131
Varshney, A., Rehan, M., Subbarao, N., Rabbani, G., & Khan, R. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017230 · Cited by 125
Hritz, J., de Ruiter, A., & Oostenbrink, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801005m · Cited by 124
Toxicity testing: creating a revolution based on new technologies
Bhogal, N., Grindon, C., Combes, R. D., & Balls, M. (2005) · Trends in biotechnology · doi:10.1016/j.tibtech.2005.04.006 · Cited by 120
Improved Ligand-Protein Binding Affinity Predictions Using Multiple Binding Modes
Stjernschantz, E., & Oostenbrink, C. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.02.034 · Cited by 119
Hervé, F., Caron, G., Duché, J.-C., Gaillard, P., Rahman, N. A., Tsantili‐Kakoulidou, A., Carrupt, P., d’Athis, P., Tillement, J. P., & Testa, B. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.129 · Cited by 116
DeKeyser, J. G., Laurenzana, E. M., Peterson, E. C., Chen, T., & Omiecinski, C. J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq394 · Cited by 115
Savas, Ü., Griffin, K. J., & Johnson, E. F. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.5.851 · Cited by 113
Challenges Predicting Ligand-Receptor Interactions of Promiscuous Proteins: The Nuclear Receptor PXR
Ekins, S., Kortagere, S., Iyer, M., Reschly, E. J., Lill, M. A., Redinbo, M. R., & Krasowski, M. D. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000594 · Cited by 110
Safa, A. R. (2004) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011043482142 · Cited by 106
Drug block of the hERG potassium channel: Insight from modeling
Stansfeld, P., Gedeck, P., Gosling, M., Cox, B., Mitcheson, J., & Sutcliffe, M. (2007) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21400 · Cited by 105
A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity
Obiol‐Pardo, C., Gomis-Tena, J., Sanz, F., Sáiz, J., & Pastor, M. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100423z · Cited by 104
Sulfotransferases, sulfatases and formylglycine-generating enzymes: a sulfation fascination
Bojarová, P., & Williams, S. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.06.018 · Cited by 103
Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs
Bisson, W. H., Cheltsov, A. V., Bruey-Sédano, N., Lin, B., Chen, J., Goldberger, N. E., May, L. T., Christopoulos, A., Dalton, J. T., Sexton, P. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609752104 · Cited by 101
Rodrigues, A. D. (2001) · CRC Press eBooks · doi:10.1201/b14003 · Cited by 99
The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections
Lagorce, D., Maupetit, J., Baell, J. B., Spérandio, O., Tufféry, P., Miteva, M. A., Galons, H., & Villoutreix, B. O. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr333 · Cited by 95
Self-citationDeeb, O., Rosales‐Hernández, M. C., Gómez-Castro, C. Z., Garduño‐Juárez, R., & Correa‐Basurto, J. (2009) · Biopolymers · doi:10.1002/bip.21314 · Cited by 94
Nishi, K., Ono, T., Nakamura, T., Fukunaga, N., Izumi, M., Watanabe, H., Suenaga, A., Maruyama, T., Yamagata, Y., Curry, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208926 · Cited by 89
Structure of human -acid glycoprotein and its high-affinity binding site
Kopecký, V., Ettrich, R. H., Hofbauerová, K., & Baumruk, V. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02765-1 · Cited by 88
Durdağı, S., Duff, H. J., & Noskov, S. Y. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100409y · Cited by 87
The Structural Basis of Pregnane X Receptor Binding Promiscuity
Ngan, C. H., Beglov, D., Rudnitskaya, A. N., Kozakov, D., Waxman, D. J., & Vajda, S. (2009) · Biochemistry · doi:10.1021/bi901578n · Cited by 84
Molecular models of human P-glycoprotein in two different catalytic states
Becker, J., Depret, G., Françoise Van Bambeke, A., Tulkens, P. M., & Prévost, M. (2009) · BMC Structural Biology · doi:10.1186/1472-6807-9-3 · Cited by 82
Interaction of Positional Isomers of Quercetin Glucuronides with the Transporter ABCC2 (cMOAT, MRP2)
Williamson, G., Herter‐Aeberli, I., Miguet, L., Zhang, Z., Sanchez, M.-B., Crespy, V., Barron, D., Needs, P. W., Kroon, P. A., Glavinas, H., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014241 · Cited by 82
Klepsch, F., Chiba, P., & Ecker, G. F. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002036 · Cited by 80
Computational Tools for Polypharmacology and Repurposing
Achenbach, J., Tiikkainen, P., Franke, L., & Proschak, E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.62 · Cited by 78
Spérandio, O., Mouawad, L., Pinto, E., Villoutreix, B. O., Pérahia, D., & Miteva, M. A. (2010) · European Biophysics Journal · doi:10.1007/s00249-010-0592-0 · Cited by 76
Self-citationZhou, D., Afzelius, L., Grimm, S. W., Andersson, T. B., Zauhar, R. J., & Zamora, I. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008631 · Cited by 75
The Flexible Pocketome Engine for Structural Chemogenomics
Abagyan, R. A., & Kufareva, I. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-274-2_11 · Cited by 72
Role of Water in Molecular Docking Simulations of Cytochrome P450 2D6
Santos, R., Hritz, J., & Oostenbrink, C. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900293e · Cited by 71
Hit Identification and Binding Mode Predictions by Rigorous Free Energy Simulations
Michel, J., & Essex, J. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800524s · Cited by 70
Kemp, C. A., Flanagan, J. U., van Eldik, A. J., Maréchal, J., Wolf, C. R., Roberts, G. C. K., Paine, M. J. I., & Sutcliffe, M. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049934e · Cited by 69
Liu, H., Bao, W., Ding, H., Jang, J., & Zou, G. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp102053x · Cited by 67
In Silico Toxicology in Drug Discovery — Concepts Based on Three-dimensional Models
Vedani, A., & Smieško, M. (2009) · Alternatives to Laboratory Animals · doi:10.1177/026119290903700506 · Cited by 65
Park, S., Kufareva, I., & Abagyan, R. A. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9362-4 · Cited by 65
Pharmaceutical Perspectives of Nonlinear QSAR Strategies
Michielan, L., & Moro, S. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100072z · Cited by 64
Smith, P. A., Sorich, M. J., Low, L. S. C., McKinnon, R. A., & Miners, J. O. (2004) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2004.03.011 · Cited by 64
Seigneuret, M., & Garnier-Suillerot, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302443200 · Cited by 58
Liu, Y.-H., Mo, S., Bi, H.-C., Hu, B.-F., Li, C. G., Wang, Y., Huang, L., Huang, M., Duan, W., Liu, J., et al. (2010) · Xenobiotica · doi:10.3109/00498254.2010.537395 · Cited by 55
Docking and High Throughput Docking: Successes and the Challenge of Protein Flexibility
Cavasotto, C. N., & Singh, N. P. (2008) · Current Computer - Aided Drug Design · doi:10.2174/157340908785747474 · Cited by 53
Utility of protein structures in overcoming ADMET-related issues of drug-like compounds
Stoll, F., Göller, A. H., & Hillisch, A. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.04.008 · Cited by 50
Taboureau, O., & Jørgensen, F. S. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711795508322 · Cited by 46
Lill, M. A., Winiger, F., Vedani, A., & Ernst, B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050403f · Cited by 45
Bazeley, P. S., Prithivi, S., Struble, C. A., Povinelli, R. J., & Sem, D. S. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600267k · Cited by 40
Pajeva, I. K., Globisch, C., & Wiese, M. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07415.x · Cited by 39
Wu, B., Morrow, J. K., Singh, R., Zhang, S., & Hu, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175356 · Cited by 39
Generalized Proteochemometric Model of Multiple Cytochrome P450 Enzymes and Their Inhibitors
Kontijevskis, A., Komorowski, J., & Wikberg, J. E. S. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci8000953 · Cited by 38
Küblbeck, J., Jyrkkärinne, J., Poso, A., Turpeinen, M., Sippl, W., Honkakoski, P., & Windshügel, B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.014 · Cited by 35
Windshügel, B., Jyrkkärinne, J., Poso, A., Honkakoski, P., & Sippl, W. (2004) · Journal of Molecular Modeling · doi:10.1007/s00894-004-0227-4 · Cited by 28
In Silico Prediction of the Chemical Block of Human Ether-a-Go-Go-Related Gene (hERG) K+ Current
Inanobe, A., Kamiya, N., Murakami, S., Fukunishi, Y., Nakamura, H., & Kurachi, Y. (2008) · The Journal of Physiological Sciences · doi:10.2170/physiolsci.rv011408 · Cited by 26
The nasty surprise of a complex drug–drug interaction
Bode, C. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.013 · Cited by 23
Stjernschantz, E., Reinen, J., Meinl, W., George, B. J., Glatt, H. R., Vermeulen, N. P. E., & Oostenbrink, C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.001 · Cited by 20
SGC - Structural Biology and Human Health: A New Approach to Publishing Structural Biology Results
Lee, W. H., Atienza-Herrero, J., Abagyan, R. A., & Marsden, B. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007675 · Cited by 19
Isvoran, A., Badel, A., Craescu, C. T., Miron, S. M., & Miteva, M. A. (2011) · BMC Structural Biology · doi:10.1186/1472-6807-11-24 · Cited by 16
Self-citationEvaluation of Virtual Screening as a Tool for Chemical Genetic Applications
Campágna‐Slater, V., & Schapira, M. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900219u · Cited by 11
Cucurull-Sanchez, L. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9361-5 · Cited by 8
(2011) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97816080514271110101 · Cited by 7
Molecular Mechanisms of Adverse Drug Reactions in Cardiac Tissue
Tabrizchi, R. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_4 · Cited by 5
Cited by
Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00104 · Cited by 5,716
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Computational Approaches in Preclinical Studies on Drug Discovery and Development
Wu, F., Zhou, Y., Li, L., Shen, X., Chen, G., Wang, X., Liang, X., Tan, M., & Huang, Z. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00726 · Cited by 446
In silico ADME/T modelling for rational drug design
Wang, Y., Xing, J., Xu, Y., Zhou, N., Peng, J., Xiong, Z., Liu, X., Luo, X., Luo, C., Chen, K., et al. (2015) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583515000190 · Cited by 367
Improving compound–protein interaction prediction by building up highly credible negative samples
Liu, H., Sun, J., Guan, J., Zheng, J., & Zhou, S. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv256 · Cited by 359
Metadata
- Authors
- Moroy, G., Martiny, V. Y., Vayer, P., Villoutreix, B. O., & Miteva, M. A.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 17
- Issue
- 1-2
- Pages
- 44-55
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2033342433
- Cited by
- 302
- References
- 101
- FWCI
- 14.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.